CONCORDBIO.NS Profit & Loss
Concord Biotech Ltd.
Profit & Loss Balance Sheet Cash Flow
Profit & Loss · 3 years on file
(FY2023-24 to FY2025-26)
· fetched 2026-08-23 21:43
| Line item | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|
| Revenue from Operations | ₹10.17 Bn | ₹12.00 Bn | ₹10.55 Bn | RevenueFromOperations |
| Gross Revenue (incl. inter-segment) | N/A | N/A | N/A | SegmentRevenueFromOperations |
| Other Income | ₹0.34 Bn | ₹0.44 Bn | ₹0.52 Bn | OtherIncome |
| Total Income | ₹10.51 Bn | ₹12.45 Bn | ₹11.07 Bn | Income |
| Cost of Materials Consumed | ₹1.85 Bn | ₹2.64 Bn | ₹2.54 Bn | CostOfMaterialsConsumed |
| Purchases of Stock-in-Trade | ₹0.57 Bn | ₹0.56 Bn | ₹0.63 Bn | PurchasesOfStockInTrade |
| Changes in Inventories | ₹-0.12 Bn | ₹-0.15 Bn | ₹-0.71 Bn | ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade |
| Employee Benefit Expense | ₹1.23 Bn | ₹1.39 Bn | ₹1.77 Bn | EmployeeBenefitExpense |
| Finance Costs | ₹0.03 Bn | ₹0.01 Bn | ₹0.00 Bn | FinanceCosts |
| Depreciation and Amortisation | ₹0.54 Bn | ₹0.54 Bn | ₹0.74 Bn | DepreciationDepletionAndAmortisationExpense |
| Other Expenses | ₹2.33 Bn | ₹2.49 Bn | ₹2.65 Bn | OtherExpenses |
| Total Expenses | ₹6.42 Bn | ₹7.49 Bn | ₹7.62 Bn | Expenses |
| Profit Before Exceptional Items and Tax | ₹4.09 Bn | ₹4.96 Bn | ₹3.45 Bn | ProfitBeforeExceptionalItemsAndTax |
| Exceptional Items | ₹0.00 Bn | ₹0.00 Bn | ₹-0.03 Bn | ExceptionalItemsBeforeTax |
| Profit Before Tax | ₹4.09 Bn | ₹4.96 Bn | ₹3.42 Bn | ProfitBeforeTax |
| Tax Expense | ₹1.04 Bn | ₹1.23 Bn | ₹0.85 Bn | TaxExpense |
| Net Profit (incl. minority interest) | ₹3.08 Bn | ₹3.72 Bn | ₹2.59 Bn | ProfitLossForPeriod |
| Net Profit (to shareholders) | ₹3.08 Bn | ₹3.72 Bn | ₹2.61 Bn | ProfitOrLossAttributableToOwnersOfParent |
| Basic EPS | ₹29.45 | ₹35.52 | ₹24.78 | BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
| Diluted EPS | ₹29.45 | ₹35.52 | ₹24.78 | DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations |
Every figure above is the exact value of the named XBRL element from CONCORDBIO.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).